These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
689 related articles for article (PubMed ID: 19067785)
1. Changes in dipole membrane potential at the mouse blood-brain barrier enhance the transport of 99mTechnetium Sestamibi more than inhibiting Abcb1, Abcc1, or Abcg2. Cattelotte J; Tournier N; Rizzo-Padoin N; Schinkel AH; Scherrmann JM; Cisternino S J Neurochem; 2009 Feb; 108(3):767-75. PubMed ID: 19067785 [TBL] [Abstract][Full Text] [Related]
2. Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier. Cisternino S; Mercier C; Bourasset F; Roux F; Scherrmann JM Cancer Res; 2004 May; 64(9):3296-301. PubMed ID: 15126373 [TBL] [Abstract][Full Text] [Related]
3. Effects of MDR1 and MDR3 P-glycoproteins, MRP1, and BCRP/MXR/ABCP on the transport of (99m)Tc-tetrofosmin. Chen WS; Luker KE; Dahlheimer JL; Pica CM; Luker GD; Piwnica-Worms D Biochem Pharmacol; 2000 Aug; 60(3):413-26. PubMed ID: 10856437 [TBL] [Abstract][Full Text] [Related]
4. ABC transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) expression in the developing human CNS. Daood M; Tsai C; Ahdab-Barmada M; Watchko JF Neuropediatrics; 2008 Aug; 39(4):211-8. PubMed ID: 19165709 [TBL] [Abstract][Full Text] [Related]
5. Ibogaine labeling with 99mTc-tricarbonyl: synthesis and transport at the mouse blood-brain barrier. Tournier N; André P; Blondeel S; Rizzo-Padoin N; du Moulinet d'Hardemarre A; Declèves X; Scherrmann JM; Cisternino S J Pharm Sci; 2009 Dec; 98(12):4650-60. PubMed ID: 19492342 [TBL] [Abstract][Full Text] [Related]
6. Evidence for an active transport of morphine-6-beta-d-glucuronide but not P-glycoprotein-mediated at the blood-brain barrier. Bourasset F; Cisternino S; Temsamani J; Scherrmann JM J Neurochem; 2003 Sep; 86(6):1564-7. PubMed ID: 12950465 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the accumulation and efflux kinetics of technetium-99m sestamibi and technetium-99m tetrofosmin in an MRP-expressing tumour cell line. Utsunomiya K; Ballinger JR; Piquette-Miller M; Rauth AM; Tang W; Su ZF; Ichise M Eur J Nucl Med; 2000 Dec; 27(12):1786-92. PubMed ID: 11189941 [TBL] [Abstract][Full Text] [Related]
8. (R)-[(11)C]verapamil is selectively transported by murine and human P-glycoprotein at the blood-brain barrier, and not by MRP1 and BCRP. Römermann K; Wanek T; Bankstahl M; Bankstahl JP; Fedrowitz M; Müller M; Löscher W; Kuntner C; Langer O Nucl Med Biol; 2013 Oct; 40(7):873-8. PubMed ID: 23845421 [TBL] [Abstract][Full Text] [Related]
9. Influence of breast cancer resistance protein (Abcg2) and p-glycoprotein (Abcb1a) on the transport of imatinib mesylate (Gleevec) across the mouse blood-brain barrier. Bihorel S; Camenisch G; Lemaire M; Scherrmann JM J Neurochem; 2007 Sep; 102(6):1749-1757. PubMed ID: 17696988 [TBL] [Abstract][Full Text] [Related]
10. The role of P-glycoprotein in intestinal transport versus the BBB transport of tetraphenylphosphonium. Swed A; Eyal S; Madar I; Zohar-Kontante H; Weiss L; Hoffman A Mol Pharm; 2009; 6(6):1883-90. PubMed ID: 19722701 [TBL] [Abstract][Full Text] [Related]
11. Characterization of multidrug resistance P-glycoprotein transport function with an organotechnetium cation. Piwnica-Worms D; Rao VV; Kronauge JF; Croop JM Biochemistry; 1995 Sep; 34(38):12210-20. PubMed ID: 7547962 [TBL] [Abstract][Full Text] [Related]
12. Transport of cryptotanshinone, a major active triterpenoid in Salvia miltiorrhiza Bunge widely used in the treatment of stroke and Alzheimer's disease, across the blood-brain barrier. Yu XY; Lin SG; Chen X; Zhou ZW; Liang J; Duan W; Chowbay B; Wen JY; Chan E; Cao J; Li CG; Zhou SF Curr Drug Metab; 2007 May; 8(4):365-78. PubMed ID: 17504224 [TBL] [Abstract][Full Text] [Related]
13. Effect of P-glycoprotein and multidrug resistance associated protein gene expression on Tc-99m MIBI imaging in hepatocellular carcinoma. Chang CS; Huang WT; Yang SS; Yeh HZ; Kao CH; Chen GH Nucl Med Biol; 2003 Feb; 30(2):111-7. PubMed ID: 12623109 [TBL] [Abstract][Full Text] [Related]
14. Renal and hepatic kinetics of Tc-99m-labelled hexakis-methoxy-isobutyl Isonitrile. Dizdarevic S; Aplin M; Ryan N; Holt SG; Goldberg L; Miles KA; Peters AM Drug Metab Lett; 2012; 6(4):242-6. PubMed ID: 23745949 [TBL] [Abstract][Full Text] [Related]
15. ABCG2- and ABCG4-mediated efflux of amyloid-β peptide 1-40 at the mouse blood-brain barrier. Do TM; Noel-Hudson MS; Ribes S; Besengez C; Smirnova M; Cisternino S; Buyse M; Calon F; Chimini G; Chacun H; Scherrmann JM; Farinotti R; Bourasset F J Alzheimers Dis; 2012; 30(1):155-66. PubMed ID: 22391220 [TBL] [Abstract][Full Text] [Related]
16. Dissimilar Effect of P-Glycoprotein and Breast Cancer Resistance Protein Inhibition on the Distribution of Erlotinib to the Retina and Brain in Humans and Mice. Biali ME; Auvity S; Cisternino S; Smirnova M; Hacker M; Zeitlinger M; Mairinger S; Tournier N; Bauer M; Langer O Mol Pharm; 2023 Nov; 20(11):5877-5887. PubMed ID: 37883694 [TBL] [Abstract][Full Text] [Related]
17. Characterisation of the brain multidrug resistance protein (BMDP/ABCG2/BCRP) expressed at the blood-brain barrier. Eisenblätter T; Hüwel S; Galla HJ Brain Res; 2003 May; 971(2):221-31. PubMed ID: 12706238 [TBL] [Abstract][Full Text] [Related]
18. Brain accumulation of sunitinib is restricted by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and can be enhanced by oral elacridar and sunitinib coadministration. Tang SC; Lagas JS; Lankheet NA; Poller B; Hillebrand MJ; Rosing H; Beijnen JH; Schinkel AH Int J Cancer; 2012 Jan; 130(1):223-33. PubMed ID: 21351087 [TBL] [Abstract][Full Text] [Related]
19. Involvement of glutathione in loss of technetium-99m-MIBI accumulation related to membrane MDR protein expression in tumor cells. Moretti JL; Duran Cordobes M; Starzec A; de Beco V; Vergote J; Benazzouz F; Boissier B; Cohen H; Safi N; Piperno-Neumann S; Kouyoumdjian JC J Nucl Med; 1998 Jul; 39(7):1214-8. PubMed ID: 9669397 [TBL] [Abstract][Full Text] [Related]
20. Blood-brain and retinal barriers show dissimilar ABC transporter impacts and concealed effect of P-glycoprotein on a novel verapamil influx carrier. Chapy H; Saubaméa B; Tournier N; Bourasset F; Behar-Cohen F; Declèves X; Scherrmann JM; Cisternino S Br J Pharmacol; 2016 Feb; 173(3):497-510. PubMed ID: 26507673 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]